BRAF and neoplasm: Specifically, NTRK1 expression was significantly higher in right-sided tumours, late pathological T stage, non-metastasis (M0) stage, MSI positive state, the hypermutated/MSI subtype, BRAF mutation-positive, low FGA state, low aneuploidy state and high TMB.